<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5554225</article-id><article-id pub-id-type="publisher-id">8510</article-id><article-id pub-id-type="doi">10.1038/s41598-017-08510-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>An effective combination of whole-exome sequencing and runs of homozygosity for the diagnosis of primary ciliary dyskinesia in consanguineous families</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Guo</surname><given-names>Ting</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Tan</surname><given-names>Zhi-Ping</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Hua-Mei</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Dong-yuan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>liu</surname><given-names>Lv</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Xin-Gang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Ping</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Luo</surname><given-names>Hong</given-names></name><address><email>Luohong1003@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Yang</surname><given-names>Yi-Feng</given-names></name><address><email>yyf627@163.com</email></address><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0379 7164</institution-id><institution-id institution-id-type="GRID">grid.216417.7</institution-id><institution>Department of Respiratory Medicine, the Second Xiangya Hospital, </institution><institution>Central South University, </institution></institution-wrap>Changsha, Hunan 410011 China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0379 7164</institution-id><institution-id institution-id-type="GRID">grid.216417.7</institution-id><institution>Research Unit of Respiratory Disease, </institution><institution>Central South University, </institution></institution-wrap>Changsha, Hunan 410011 China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0379 7164</institution-id><institution-id institution-id-type="GRID">grid.216417.7</institution-id><institution>Diagnosis and Treatment Center of Respiratory Disease, </institution><institution>Central South University, </institution></institution-wrap>Changsha, Hunan 410011 China </aff><aff id="Aff4"><label>4</label>Central South University Center for Clinical Gene Diagnosis and Treatment, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011 China </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0379 7164</institution-id><institution-id institution-id-type="GRID">grid.216417.7</institution-id><institution>Department of Cardiovascular Surgery, the Second Xiangya Hospital, </institution><institution>Central South University, </institution></institution-wrap>Changsha, Hunan 410011 China </aff><aff id="Aff6"><label>6</label>Department of Respiratory Medicine, Chang Sha Central Hospital, Changsha, Hunan 410011 China </aff></contrib-group><pub-date pub-type="epub"><day>11</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>11</day><month>8</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>7</volume><elocation-id>7905</elocation-id><history><date date-type="received"><day>7</day><month>7</month><year>2016</year></date><date date-type="accepted"><day>11</day><month>7</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Primary ciliary dyskinesia (PCD) is clinically characterized by neonatal respiratory distress, chronic sinusitis, bronchiectasis and infertility, and situs inversus in 50% of the patients. PCD is a result of mutations in genes encoding proteins involved in ciliary function, and is primarily inherited in an autosomal recessive fashion. Diagnosis of PCD is often a challenging task due to its high clinical and genetic heterogeneities. In the present study, we attempted to use whole-exome sequencing (WES) combined with runs of homozygosity (ROH) approaches to identify the genetic defects in four Chinese consanguineous families with clinical PCD. We successfully identified three recently acknowledged PCD genes: <italic>DYX1C1</italic>, <italic>CCNO</italic> and <italic>ARMC4</italic>, and one well-characterized PCD gene, <italic>DNAI1</italic>. Our study provides compelling evidence that WES in combination with ROH analysis is an efficient diagnostic tool for identifying genetic causes of PCD in consanguineous families. Furthermore, our work expands the genetic mutation spectrum in PCD, and provides the additional tools to better serve the counseling of the families with PCD.</p></abstract><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Primary ciliary dyskinesia (PCD; MIM: 244400) is a clinically heterogeneous disorder due to impairment of ciliary function and has an estimated prevalence of approximately 1 in 15,000&#x02013;20,000 individuals<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Ineffective cilium movement of cells lining the upper and lower respiratory tracts may result in limited mucus clearance, leading to neonatal respiratory distress, rhinitis, sinusitis, rhinorrhea, chronic cough, recurrent respiratory infections and bronchiectasis. Male infertility may occur as functional cilia are required for proper sperm flagella function. Approximately 50% of the PCD patients present with situs inversus due to the cilium dysfunction during early embryonic development<sup><xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref></sup>.</p><p id="Par3">Currently, there is no &#x0201c;gold standard&#x0201d; reference test for PCD. The traditional diagnosis of PCD largely depends on the careful evaluation of clinical features, ciliary function, ultrastructural defects, nasal nitric oxide (nNO) levels, and genetic analysis<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. However, some of these diagnostic approaches are not easily accessible and require specialized expertise. Some tests are challenging due to the heterogeneity of the disease, including atypical or overlapping phenotypes, which could lead to incorrect clinical diagnosis and suboptimal treatment.</p><p id="Par4">PCD is primarily a rare autosomal recessive disorder caused by mutations in genes encoding proteins involved in cilium function<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. As a Mendelian genetic disorder, PCD can be identified through genetic analysis. Since the first identified disease gene <italic>DNAI1</italic> in PCD patients with immotile respiratory cilia in&#x000a0;1999<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>, remarkable efforts have been made to define the genetic cause of PCD. So far, genetic mutations in over 40 genes account for an estimated 65% of individuals<sup><xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR10">10</xref></sup>. However, approximately 35% of PCD individuals remain genetic elusive<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>, highlighting the genetic heterogeneity and challenges of using conventional targeted gene panels based on the currently known PCD-associated genes. Recently, WES in combination with multiple strategies, including runs of homozygosity (ROH)<sup><xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref></sup>, linkage analysis<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>, and filtering of reported disease-related genes<sup><xref ref-type="bibr" rid="CR15">15</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref></sup>, have shown tremendous potentials for genetic diagnosis and for identification of novel variants. In some cases, these strategies appear to be the only way for achieving a precise diagnosis<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>.</p><p id="Par5">The prevalence of PCD has a higher rate in consanguineous families<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> and has been occasionally reported in China. We hypothesize that the consanguineous families with PCD provide a great opportunity to recover novel causative PCD gene(s). In the present study, we examine the clinical diagnosis of PCD with WES in combination with ROH. Six PCD patients from four consanguineous families were analyzed using WES, and a total of four PCD causative genes, <italic>CCNO</italic>, <italic>DYX1C1</italic>, <italic>ARMC4</italic> and <italic>DNAI1</italic> were identified in these consanguineous families.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and Methods</title><sec id="Sec3"><title>Patients and subjects</title><p id="Par6">The study protocol was approved by the Review Board of the Second Xiangya Hospital of Central South University in China. Informed consent was obtained from all subjects. All experiments were performed in accordance with the relevant guidelines and regulations. Four consanguineous families with PCD were recruited, in which one individual was affected in families 1 and 4, and two individuals were affected in families 2 and 3. The medical records of the subjects, including pulmonary, paranasal sinus, abdominal computed tomography (CT) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> and Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>), nNO level<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>, and transmission electron microscopy (TEM) findings (Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>) were documented and reviewed.<fig id="Fig1"><label>Figure 1</label><caption><p>Clinical features of PCD in the consanguineous families. The patient (P6 from family 4) presented the classical clinical features of PCD. (<bold>A</bold>) The chest computed tomography (CT) scan showed bronchiectasis. (<bold>B</bold>) The paranasal sinus CT scan of the patient showed apparent rhinosinusitis. Typical situs inversus is shown in C, D. CT images of the remaining patients are shown in Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref>.</p></caption><graphic xlink:href="41598_2017_8510_Fig1_HTML" id="d29e454"/></fig>
</p></sec><sec id="Sec4"><title>WES and filtering</title><p id="Par7">Blood samples (3&#x02013;5&#x02009;ml) were obtained from the affected probands and their family members (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Genomic DNA was extracted using the DNeasy Blood &#x00026; Tissue Kit (Qiagen, Valencia, CA). Whole-exome capture and high-throughput sequencing (HTS) were performed by the Novogene Bioinformatics Institute (Beijing, China). Briefly, whole exomes were captured using the Agilent SureSelect Human All ExonV5 Kit (Agilent, California, USA) and sequenced on the Illumina HiSeq. 2500 platform. The sequencing reads were aligned to the human reference genome (UCSC hg19), and the details of the sequencing data are provided in Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>. Single nucleotide variants (SNVs) and short insertions and deletions (InDels) were filtered as follows: (i) Variants within intergenic, intronic, and UTR regions and synonymous mutations were excluded from subsequent analyses. (ii) High-frequency (minor allele frequency &#x0003e;0.01) polymorphisms found in the 1000 Genomes Project, ESP6500, Exac, and Novogene Bioinformatics Institute in-house exomeSeq databases were excluded. (iii) Based on the principle that the identification of a new disease-causing gene should exclude known causal genes<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, variants in the 40 PCD-related genes (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>) were selected. This approach prevented the omission of any compound heterozygotes of known genes. (iv) Due to the examination of consanguineous families, ROH<sup><xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref></sup> analysis was performed. ROH analysis is an important approach because it can effectively exclude false-positive variants in the case of a large deletion on the other allele. The detailed steps of filtering are shown in Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">3</xref>.<fig id="Fig2"><label>Figure 2</label><caption><p>Pedigree of the families and the Sanger DNA sequencing chromatogram of the patients. Roman numerals refer to generations, and individuals within a generation are numbered from left to right. Black circles/squares are affected, and white circles/squares are unaffected. Arrows indicate the probands. P1-P6 are the probands (P1 refers to IV-4 in family 1; P2 and P3 refer to IV-1 and IV-2 in family 2, respectively; P4 and P5 refer to IV-2 and IV-3 in family 3, respectively; and P6 refers to IV-5 in family 4). Seven large circles (in red) represent the 7 individuals who underwent WES. The Sanger sequencing chromatogram of the affected patient, unaffected carrier, and control is shown under each pedigree. The genotype is indicated in the pedigree charts:+/+, affected patient (homozygous mutation);+/&#x02212;, unaffected carrier (heterozygous mutation); and &#x02212;/&#x02212;, unaffected control.</p></caption><graphic xlink:href="41598_2017_8510_Fig2_HTML" id="d29e493"/></fig>
</p></sec><sec id="Sec5"><title>Bioinformatic analysis</title><p id="Par8">The effect of the identified variants on protein function was predicted using bioinformatic programs (Sift, Polyphen-2, MutationTaster, PROVEAN, LRT and MutationAssessor), and potential effects on protein structure were determined using the Swiss Model tool. To evaluate the degree of conservation, alignment of the amino acid sequences of the targeted genes from various species was obtained from MutationTaster (<ext-link ext-link-type="uri" xlink:href="http://www.mutationtaster.org">http://www.mutationtaster.org</ext-link>), and domain analyses were performed (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi">http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi</ext-link>).</p></sec><sec id="Sec6"><title>Mutation validation and co-segregation analysis</title><p id="Par9">Sanger sequencing was used to validate the candidate variants identified by WES, and segregation analyses were performed in the family members. Primer pairs were designed using an online tool (PrimerQuest, IDT), and the sequences of the primers are listed in Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S3</xref>.</p></sec></sec><sec id="Sec7" sec-type="results"><title>Results</title><sec id="Sec8"><title>Clinical features</title><p id="Par10">Six PCD patients (P1&#x02013;6) (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>) from four consanguineous families (families 1 to 4) (full pedigrees are shown in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) were identified. P1 refers to IV-4 in family 1; P2 and P3 refer to IV-1 and IV-2 in family 2, respectively; P4 and P5 refer to IV-2 and IV-3 respectively in family 3; and P6 refers to IV-5 in family 4 (see Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). The parents of all probands are first cousins, and the inbreeding coefficient (F) is 1/16 for each family. All patients in these families presented with typical PCD manifestations, including recurrent upper and lower respiratory infections from childhood, bronchiectasis, chronic rhinosinusitis, left-right laterality, reduced nNO or infertility. The specific clinical manifestations of each patient are shown in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of the clinical features of PCD.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Characteristics</th><th>P1 (family1:IV-4)</th><th>P2 (family2:IV-1)</th><th>P3 (family2: IV-2)</th><th>P4 (family3: IV-2)</th><th>P5 (family3: IV-3)</th><th>P6 (family4: IV-5)</th></tr></thead><tbody><tr><td>Sex</td><td>Female</td><td>Male</td><td>Female</td><td>Female</td><td>Male</td><td>Female</td></tr><tr><td>Age</td><td>60 y</td><td>29 y</td><td>23 y</td><td>43 y</td><td>41 y</td><td>52 y</td></tr><tr><td>Onset</td><td>Childhood</td><td>Childhood</td><td>Childhood</td><td>Childhood</td><td>Childhood</td><td>Childhood</td></tr><tr><td>Consanguinity</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td></tr><tr><td>Inbreeding coefficient</td><td>1/16</td><td>1/16</td><td>1/16</td><td>1/16</td><td>1/16</td><td>1/16</td></tr><tr><td>CT</td><td>Bronchiectasis Rhinosinusitis Visceral inversion</td><td>Bronchiectasis Rhinosinusitis</td><td>Bronchiectasis Rhinosinusitis</td><td>Bronchiectasis Rhinosinusitis Visceral inversion</td><td>Bronchiectasis Rhinosinusitis Visceral inversion</td><td>Bronchiectasis Rhinosinusitis Visceral inversion</td></tr><tr><td>Fertility problems</td><td>No</td><td>Unknown</td><td>Unknown</td><td>Yes</td><td>Yes</td><td>No</td></tr><tr><td>Smell problems</td><td>No</td><td>No</td><td>No</td><td>Yes</td><td>Yes</td><td>No</td></tr><tr><td>Hearing problems</td><td>No</td><td>No</td><td>No</td><td>No</td><td>No</td><td>No</td></tr><tr><td>Comorbidities</td><td>Asthma</td><td>No</td><td>No</td><td>TGA,ASD,PAH</td><td>No</td><td>Asthma</td></tr><tr><td>TEM</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>Equivocal</td></tr><tr><td>PFT</td><td/><td/><td/><td/><td/><td/></tr><tr><td>FEV1%</td><td>32%</td><td>33%</td><td>49%</td><td>44%</td><td>NA</td><td>37.2%</td></tr><tr><td>FEV1/FVC</td><td>40.21%</td><td>54.73%</td><td>50%</td><td>60%</td><td>NA</td><td>36.37%</td></tr><tr><td>PaO2</td><td>NA</td><td>78&#x02009;mmHg</td><td>82&#x02009;mmHg</td><td>80&#x02009;mmHg</td><td>NA</td><td>NA</td></tr><tr><td>Nasal NO</td><td>23.6 ppb</td><td>3.3 ppb</td><td>31 ppb</td><td>2.3 ppb</td><td>8.3 ppb</td><td>16.1 ppb</td></tr></tbody></table><table-wrap-foot><p>TGA, corrected transposition of great arteries; ASD, atrial septal defect; PAH, pulmonary arterial hypertension; TEM, transmission electron microscopy; PFT, pulmonary function test; FEV1, forced expiratory volume in 1&#x02009;second; FVC, forced vital capacity; Nasal NO, nasal nitric oxide measurement; NA, not available.</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec9"><title>Genetic analysis</title><p id="Par11">WES was performed on seven individuals (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Sequence read of 7.88, 5.65, 4.9, 8.63, 8.23, 5.46 and 6.48 Gbp were generated, with a depth of more than 50&#x02009;&#x000d7;&#x02009;for each individual, and more than 99% of the targeted bases were covered sufficiently to pass our thresholds for SNVs and InDels (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>). Exonic InDels, non-synonymous variants, and nonsense and splice-site SNVs were further filtered. After the discovery of rare variations (minor allele frequency &#x0003c;1%), selection of variants in the 40 PCD-related genes (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>) was performed. The coverage of the whole exome by the exome capture kit was approximately 99.7&#x02013;99.8%, and the coverage of the 40 known PCD genes was greater than 99% (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S4</xref>). No compound heterozygotes of known PCD-related genes were identified in these patients. Interestingly, only one homozygous mutation in a known PCD gene was identified in each family (c.1488delG of <italic>ARMC4</italic> in family 1, c.248_249insGCCCG of <italic>CCNO</italic> in family 2, c.384delC of <italic>DYX1C1</italic> in family 3, and c.1562T&#x02009;&#x0003e;&#x02009;G of <italic>DNAI1</italic> in family 4). All four variants were validated via Sanger sequencing (the PCR primers are listed in Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S3</xref>). The sequences of these genes from each of these four families were determined, and the variations were found to co-segregate with the disease in each family (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).The frequencies of the identified variants in the public databases (Exac, ClinVar, NHLBI exome databases, dbSNP138, 1000 Genomes Project) are shown in Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S5</xref>.</p><p id="Par12">Among the four apparently homozygous variants identified in our study, three were nonsense/frameshift mutations and one was missense mutation (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). To exclude the possibility of a large deletion of the other homologous allele, we performed ROH analysis<sup><xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref></sup>. In accordance with the autosomal recessive pattern of inheritance, our data from ROH analysis confirmed the homozygous conditions of these four mutations in all four PCD families.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Functional prediction and conservation analysis for the cosegregating mutation</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Family</th><th>Gene</th><th>NM</th><th>Base change</th><th>AAchange</th><th>MutationTaster</th><th>PROVEAN</th><th>SIFT</th><th>Polyphen2</th><th>LRT</th><th>MutationAssessor</th><th>CADD</th><th>GERP++</th><th>phylop100way</th></tr></thead><tbody><tr><td>1</td><td>
<italic>ARMC4</italic>
</td><td>018076</td><td>1488delG</td><td>E497Kfs*3</td><td>Disease-causing</td><td>Deleterious</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>2</td><td>
<italic>CCNO</italic>
</td><td>021147</td><td>248_249insGCCCG</td><td>Q88Rfs*8</td><td>Disease-causing</td><td>Deleterious</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>3</td><td>
<italic>DYX1C1</italic>
</td><td>130810</td><td>384delC</td><td>Y128*</td><td>Disease-causing</td><td>Deleterious</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>4</td><td>
<italic>DNAI1</italic>
</td><td>012144</td><td>T1562G</td><td>I521S</td><td>Probably damaging</td><td>Deleterious</td><td>Damaging</td><td>Disease-causing</td><td>Deleterious</td><td>Medium</td><td>23</td><td>5.95</td><td>7.002</td></tr></tbody></table><table-wrap-foot><p>CADD, a value&#x02009;&#x0003e;&#x02009;15 indicates deleterious; GERP++, a score&#x02009;&#x0003e;&#x02009;5 indicates highly conserved; phylop100way, the higher the score, the more conserved the site AA, amino acid NA, not available.</p></table-wrap-foot></table-wrap>
</p><p id="Par13">Consistent with the loss of function mechanisms of the known PCD-linked genes, the mutations identified in <italic>ARMC4</italic>, <italic>CCNO</italic>, and <italic>DYX1C1</italic> in three of the families are either deletions or insertions, leading to loss of function by causing truncation of the encoded proteins. However, c.1562T&#x02009;&#x0003e;&#x02009;G (I521S) of <italic>DNAI1</italic>, found in family 4, was a missense mutation that alters a highly conserved residue (Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">4</xref>). The I521S mutation was predicted to be damaging according to SIFT, Polyphen2, MutationTaster, PROVEAN, LRT and MutationAssessor. The GERP score was 5.95 (prediction: highly conserved); the CADD value was 23 (prediction: deleterious); and the phylop100way value was 7.002 (prediction: conserved) (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Domain analysis suggested all of the variants were located in key domains that are essential for function of cilia (Supplementary Figures&#x000a0;<xref rid="MOESM1" ref-type="media">4</xref> and <xref rid="MOESM1" ref-type="media">5</xref>).</p><p id="Par14">The identified <italic>CCNO</italic> variant (Table&#x000a0;<xref rid="Tab2" ref-type="table">2)</xref> (c.248_249insGCCCG/p.Q88Rfs*8)<sup><xref ref-type="bibr" rid="CR22">22</xref></sup> was previously reported to be linked to PCD. The remaining three mutations are novel (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). None of these three mutations were found in our in-house 200 controls and other public databases, including ExAC.<fig id="Fig3"><label>Figure 3</label><caption><p>Schematic drawing of <italic>ARMC4</italic>, <italic>DYX1C1</italic>, and <italic>DNAI1</italic>, in which the positions of all identified mutations are indicated. Novel mutations that were identified in the present study are indicated in red.</p></caption><graphic xlink:href="41598_2017_8510_Fig3_HTML" id="d29e1293"/></fig>
</p></sec></sec><sec id="Sec10" sec-type="discussion"><title>Discussion</title><p id="Par15">In the present study, WES combined with ROH was employed to determine the causative genes in four consanguineous families with PCD. Four distinct homozygous mutations were identified in these families. Among them, three of the variants are either deletions or insertions leading to frameshift (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Our findings are consistent with previous studies that the majority of mutations reported in PCD patients are null alleles (nonsense or frameshift variants)<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. A novel missense variant (c.1562T&#x02009;&#x0003e;&#x02009;G/p.I521S) in <italic>DNAI1</italic> was identified in Family 4 and was predicted to be disease-causing variant by different in silico prediction methods. This variant site (I521) located in the WD40 domain, a key domain for the assembly and maintenance of cilia, strongly indicates the <italic>DNAI1</italic> variant is causative in this case. Cumulatively, a total of 12 missense mutations (out of the 27, Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) have been reported in <italic>DNAI1</italic>. Among these, several missense mutations closely flanking I521, including L513P, G515S, S527A and A538T<sup><xref ref-type="bibr" rid="CR24">24</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref></sup> have previously been identified in PCD, suggesting missense mutations represent a significant fraction of PCD-linked mutations in <italic>DNAI1</italic>.</p><p id="Par16">The identification of ultrastructural defects through transmission electron microscopy (TEM) has been previously considered a &#x0201c;gold standard&#x0201d; diagnostic test for PCD<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. However, it was challenged by recent findings<sup><xref ref-type="bibr" rid="CR29">29</xref>&#x02013;<xref ref-type="bibr" rid="CR32">32</xref></sup>, due to its limited sensitivity. Approximately 30% of patients with genetically verified PCD exhibit a normal ciliary ultrastructure<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Of note, defective cilia have also been found in 3 to 10% of healthy individuals<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. In our study, the affected individuals present some of the typical PCD manifestations such as: recurrent respiratory infections, bronchiectasis, left-right laterality and low nasal nitric oxide (nNO) levels (3.3&#x02013;31 ppb in contrast to normal values &#x0003e;100 ppb) (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). However, the TEM results of the only obtained ciliated sample from P6 are not conclusive (Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">2</xref>). In consistent with European guidelines for PCD diagnosis, we further employed WES to investigate these consanguineous families. In the absence of TEM evidence, our strategy emphasizes a role of genetic testing in the PCD diagnostic, especially in cases with difficulties using other diagnostic approaches (e.g., HSVA, TEM or IF)<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>.</p><p id="Par17">In the present study, the filtering of the 40 PCD genes was performed prior to ROH analysis, as this order allowed the identification of compound heterozygotes in known PCD genes. Copy number variations are prevalent in many autosomal recessive diseases<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. However, the detection of copy number variations using WES data remains challenging<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. ROH analysis presents the advantages of determining the exact nature of mutations in this aspect. Our findings are consistent with a recent report<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> in which WES combined with ROH was shown to be a superior choice for genetic studies in consanguineous families. As our study was primarily aimed at detecting PCD mutations, we did not actively search for &#x0201c;the incidental findings&#x0201d; that are recently recommended by the American College of Medical Genetics and Genomics<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>.</p><p id="Par18">To date, a total of 40 known PCD-causing genes have been reported (Supplementary Table&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>). Among these genes, <italic>ARMC4</italic> (MIM: 615408) encodes a protein required in a late step for proper targeting and anchoring of outer dynein arms (ciliary structure proteins)<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. Thus far, 9 different <italic>ARMC4</italic> mutations (2 missense mutants, 6 truncated mutants, and 1 frameshift mutant) have been identified in PCD patients (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>), with most of these mutations being found in exons 17 and 12. The frameshift mutation <italic>ARMC4</italic> (c.1488delG/p.E497Kfs*3) in our study is located in the ARM-repeat unit (ARM) domain (Supplementary Figure&#x000a0;<xref rid="MOESM1" ref-type="media">4</xref>) and is predicted to cause premature protein truncation, resulting in the assembly defect of the outer dynein arm.</p><p id="Par19">The <italic>DYX1C1</italic> gene (MIM: 608706) was another gene reported to be involved in PCD<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. <italic>DYX1C1</italic> encodes a 420-amino acid protein with 3 tetratricopeptide repeat (TPR) domains that are thought to be protein interaction modules. DYX1C1 is a cytoplasmic axonemal dynein assembly factor, acting together with DNAAF2 at an early step in the cytoplasmic assembly of the inner and outer dynein arms<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. To date, seven pathogenic variants of <italic>DYX1C1</italic> have been reported<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. Our finding that a single-base deletion of C at position 384 (c.384delC) results in p.Y128* is consistent with the previous report by Tarkar <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>.</p><p id="Par20">The pathogenetic variant (c.248_249insGCCCG/p.Q88Rfs*8) identified in <italic>CCNO</italic> (MIM: 607752) was previously reported<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. Due to the lack of situs inversus phenotype, the patients in family 2 were initially diagnosed with common pulmonary infection and bronchiectasis. Additional examinations revealed that both siblings exhibited chronic sinusitis symptoms, which was further confirmed via computerized tomography (CT) scan of the paranasal sinuses. Genetic analysis identified only one candidate variant <italic>CCNO</italic> (c.248_249insGCCCG/p.Q88Rfs*8). <italic>CCNO</italic> promotes mother centriole amplification and maturation in preparation for apical docking and ciliogenesis. The phenotype of our patients was consistent with the observation in previous study<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. Retrospective study revealed a delayed diagnosis in our patient due to the atypical clinical PCD features (without situs inversus)<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. This highlights the advantage of early genetic analysis with WES to obtain an efficient diagnosis and management of PCD patients in cases of consanguinity.</p><p id="Par21">In summary, using a combination of WES, ROH and bioinformatics analyses, three novel homozygous variants, including <italic>ARMC4</italic> (c.1488delG/p.E497Kfs*3), <italic>DYX1C1</italic> (c.384delC/p.Y128*) and <italic>DNAI1</italic> (c.1562T&#x02009;&#x0003e;&#x02009;G/p.I521S), and one previously reported variant, <italic>CCNO</italic> (c.248_249insGCCCG/p.Q88Rfs*8), were identified in four PCD families. The identification of these variants contributes to the growing number of candidate mutations associated with PCD and might benefit future genetic counseling. Our data have also demonstrated a great value of WES combined with ROH in PCD diagnosis in consanguineous families, especially when the other diagnostic tests fail to be conclusive.</p></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><sec id="Sec11"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2017_8510_MOESM1_ESM.pdf"><caption><p>Supplementary</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p>Ting Guo and Zhi-Ping Tan contributed equally to this work.</p></fn><fn><p><bold>Electronic supplementary material</bold></p><p>
<bold>Supplementary information</bold> accompanies this paper at doi:10.1038/s41598-017-08510-z
</p></fn><fn><p>
<bold>Publisher's note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank all the patients and their family for participating in the present study. We thank the State Key Laboratory of Medical Genetics of China for technical assistance. This study was supported by the National Natural Science Foundation of China (81470202 to Hong Luo, 81470445 to Zhi-Ping Tan, 81570288 to Yi-Feng Yang), the Natural Science Foundation of Hunan Province, China (13JJ3020 to Hong Luo), the Planned Science and Technology Project of Hunan Province, China (2015JC3032 to Yi-Feng Yang), the Science and Technology Program of Changsha, China (K1406020&#x02013;31 to Hong Luo), and the National Key Clinical Specialty Construction Projects of China.</p></ack><notes notes-type="author-contribution"><title>Author Contributions</title><p>Conceived and designed the experiments: Hong Luo and Yi-Feng Yang. Performed the experiments: Zhi-Ping Tan, Ting Guo, Lv liu. Collected samples: Ting Guo, Hua-Mei Chen, Dong-yuan Zheng, Xin-Gang Huang. Analyzed the data: Hong Luo, Ping Chen, Ting Guo, Zhi-Ping Tan. Wrote the text of the main manuscript and prepared the figures: Ting Guo. All authors reviewed the manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar1"><title>Competing Interests</title><p id="Par22">The authors declare that they have no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobo</surname><given-names>J</given-names></name><name><surname>Zariwala</surname><given-names>MA</given-names></name><name><surname>Noone</surname><given-names>PG</given-names></name></person-group><article-title>Primary ciliary dyskinesia</article-title><source>Semin. Respir. Crit. Care Med.</source><year>2015</year><volume>36</volume><fpage>169</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1055/s-0035-1546748</pub-id><?supplied-pmid 25826585?><pub-id pub-id-type="pmid">25826585</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname><given-names>C</given-names></name><name><surname>Onnebrink</surname><given-names>JG</given-names></name><name><surname>Omran</surname><given-names>H</given-names></name></person-group><article-title>Diagnosis and management of primary ciliary dyskinesia</article-title><source>Cilia</source><year>2015</year><volume>4</volume><fpage>2</fpage><pub-id pub-id-type="doi">10.1186/s13630-014-0011-8</pub-id><?supplied-pmid 25610612?><pub-id pub-id-type="pmid">25610612</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennarun</surname><given-names>G</given-names></name><etal/></person-group><article-title>Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia</article-title><source>AM J HUM GENET</source><year>1999</year><volume>65</volume><fpage>1508</fpage><pub-id pub-id-type="doi">10.1086/302683</pub-id><?supplied-pmid 10577904?><pub-id pub-id-type="pmid">10577904</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review</article-title><source>Pediatr. Pulmonol.</source><year>2016</year><volume>51</volume><fpage>115</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1002/ppul.23304</pub-id><?supplied-pmid 26418604?><pub-id pub-id-type="pmid">26418604</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olbrich</surname><given-names>H</given-names></name><etal/></person-group><article-title>Loss-of-function GAS8 mutations cause primary ciliary dyskinesia and disrupt the Nexin-Dynein regulatory complex</article-title><source>Am. J. Hum. Genet.</source><year>2015</year><volume>97</volume><fpage>546</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2015.08.012</pub-id><?supplied-pmid 26387594?><pub-id pub-id-type="pmid">26387594</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group><article-title>DNAH6 and its interactions with PCD genes in heterotaxy and primary ciliary dyskinesia</article-title><source>PLOS Genet.</source><year>2016</year><volume>12</volume><fpage>e1005821</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1005821</pub-id><?supplied-pmid 26918822?><pub-id pub-id-type="pmid">26918822</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallmeier</surname><given-names>J</given-names></name><etal/></person-group><article-title>TTC25 deficiency results in defects of the outer dynein arm docking machinery and primary ciliary dyskinesia with left-right body asymmetry randomization</article-title><source>Am. J. Hum. Genet.</source><year>2016</year><volume>99</volume><fpage>460</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2016.06.014</pub-id><?supplied-pmid 27486780?><pub-id pub-id-type="pmid">27486780</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="other">El Khouri, E. <italic>et al</italic>. Mutations in DNAJB13, encoding an HSP40 family member, cause primary ciliary dyskinesia and male infertility. <italic>Am. J. Hum. Genet.</italic><bold>99</bold>, 489&#x02013;500 (2016).</mixed-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paff</surname><given-names>T</given-names></name><etal/></person-group><article-title>Mutations in PIH1D3 cause X-linked primary ciliary dyskinesia with outer and inner dynein arm defects</article-title><source>Am. J. Hum. Genet.</source><year>2017</year><volume>100</volume><fpage>160</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2016.11.019</pub-id><?supplied-pmid 28041644?><pub-id pub-id-type="pmid">28041644</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Edelbusch, C. <italic>et al</italic>. Mutation of serine/threonine protein kinase 36 (STK36) causes primary ciliary dyskinesia with a central pair defect. <italic>HUM MUTAT</italic> (2017).</mixed-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurkowiak</surname><given-names>M</given-names></name><name><surname>Zi&#x00119;tkiewicz</surname><given-names>E</given-names></name><name><surname>Witt</surname><given-names>M</given-names></name></person-group><article-title>Recent advances in primary ciliary dyskinesia genetics</article-title><source>J. Med. Genet.</source><year>2015</year><volume>52</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1136/jmedgenet-2014-102755</pub-id><?supplied-pmid 25351953?><pub-id pub-id-type="pmid">25351953</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magi</surname><given-names>A</given-names></name><etal/></person-group><article-title>H3M2: detection of runs of homozygosity from whole-exome sequencing data</article-title><source>BIOINFORMATICS.</source><year>2014</year><volume>30</volume><fpage>2852</fpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu401</pub-id><?supplied-pmid 24966365?><pub-id pub-id-type="pmid">24966365</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pippucci</surname><given-names>T</given-names></name><etal/></person-group><article-title>Homozygous NOTCH3 null mutation and impaired NOTCH3 signaling in recessive early-onset arteriopathy and cavitating leukoencephalopathy</article-title><source>EMBO Mol. Med.</source><year>2015</year><volume>7</volume><fpage>848</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.15252/emmm.201404399</pub-id><?supplied-pmid 25870235?><pub-id pub-id-type="pmid">25870235</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>SNP linkage analysis and whole exome sequencing identify a novel POU4F3 mutation in autosomal dominant late-onset nonsyndromic hearing loss (DFNA15)</article-title><source>PLOS ONE.</source><year>2013</year><volume>8</volume><fpage>e79063</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0079063</pub-id><?supplied-pmid 24260153?><pub-id pub-id-type="pmid">24260153</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JJ</given-names></name><name><surname>Fan</surname><given-names>LL</given-names></name><name><surname>Chen</surname><given-names>JL</given-names></name><name><surname>Tan</surname><given-names>ZP</given-names></name><name><surname>Yang</surname><given-names>YF</given-names></name></person-group><article-title>A novel variant in TBX20 (p.D176N) identified by whole-exome sequencing in combination with a congenital heart disease related gene filter is associated with familial atrial septal defect</article-title><source>J. Zhejiang Univ. Sci. B.</source><year>2014</year><volume>15</volume><fpage>830</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.1631/jzus.B1400062</pub-id><?supplied-pmid 25183037?><pub-id pub-id-type="pmid">25183037</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djakow</surname><given-names>J</given-names></name><etal/></person-group><article-title>An effective combination of sanger and next generation sequencing in diagnostics of primary ciliary dyskinesia</article-title><source>Pediatr. Pulmonol.</source><year>2016</year><volume>51</volume><fpage>498</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1002/ppul.23261</pub-id><?supplied-pmid 26228299?><pub-id pub-id-type="pmid">26228299</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>CR</given-names></name><etal/></person-group><article-title>Whole-exome sequencing and targeted copy number analysis in primary ciliary dyskinesia</article-title><source>G3 (Bethesda).</source><year>2015</year><volume>5</volume><fpage>1775</fpage><lpage>1781</lpage><pub-id pub-id-type="doi">10.1534/g3.115.019851</pub-id><?supplied-pmid 26139845?><pub-id pub-id-type="pmid">26139845</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>ZP</given-names></name><etal/></person-group><article-title>Whole-exome sequencing identifies Y1495X of SCN5A to be associated with familial conduction disease and sudden death</article-title><source>Sci. Rep.</source><year>2014</year><volume>4</volume><fpage>5616</fpage><pub-id pub-id-type="doi">10.1038/srep05616</pub-id><?supplied-pmid 25010007?><pub-id pub-id-type="pmid">25010007</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rabbani</surname><given-names>B</given-names></name><name><surname>Mahdieh</surname><given-names>N</given-names></name><name><surname>Hosomichi</surname><given-names>K</given-names></name><name><surname>Nakaoka</surname><given-names>H</given-names></name><name><surname>Inoue</surname><given-names>I</given-names></name></person-group><article-title>Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders</article-title><source>J. Hum. Genet.</source><year>2012</year><volume>57</volume><fpage>621</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1038/jhg.2012.91</pub-id><?supplied-pmid 22832387?><pub-id pub-id-type="pmid">22832387</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onoufriadis</surname><given-names>A</given-names></name><etal/></person-group><article-title>Combined exome and whole-genome sequencing identifies mutations in ARMC4 as a cause of primary ciliary dyskinesia with defects in the outer dynein arm</article-title><source>J. Med. Genet.</source><year>2014</year><volume>51</volume><fpage>61</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1136/jmedgenet-2013-101938</pub-id><?supplied-pmid 24203976?><pub-id pub-id-type="pmid">24203976</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>WT</given-names></name><name><surname>Jackson</surname><given-names>CL</given-names></name><name><surname>Lackie</surname><given-names>PM</given-names></name><name><surname>Hogg</surname><given-names>C</given-names></name><name><surname>Lucas</surname><given-names>JS</given-names></name></person-group><article-title>Nitric oxide in primary ciliary dyskinesia</article-title><source>Eur. Respir. J.</source><year>2012</year><volume>40</volume><fpage>1024</fpage><lpage>1032</lpage><pub-id pub-id-type="doi">10.1183/09031936.00176111</pub-id><?supplied-pmid 22408195?><pub-id pub-id-type="pmid">22408195</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallmeier</surname><given-names>J</given-names></name><etal/></person-group><article-title>Mutations in CCNO result in congenital mucociliary clearance disorder with reduced generation of multiple motile cilia</article-title><source>Nat. Genet.</source><year>2014</year><volume>46</volume><fpage>646</fpage><lpage>651</lpage><pub-id pub-id-type="doi">10.1038/ng.2961</pub-id><?supplied-pmid 24747639?><pub-id pub-id-type="pmid">24747639</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Praveen</surname><given-names>K</given-names></name><name><surname>Davis</surname><given-names>EE</given-names></name><name><surname>Katsanis</surname><given-names>N</given-names></name></person-group><article-title>Unique among ciliopathies: primary ciliary dyskinesia, a motile cilia disorder</article-title><source>F1000Prime Rep.</source><year>2015</year><volume>7</volume><fpage>36</fpage><pub-id pub-id-type="doi">10.12703/P7-36</pub-id><?supplied-pmid 25926987?><pub-id pub-id-type="pmid">25926987</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zi&#x00119;tkiewicz</surname><given-names>E</given-names></name><etal/></person-group><article-title>Population specificity of the DNAI1 gene mutation spectrum in primary ciliary dyskinesia (PCD)</article-title><source>Respir. Res.</source><year>2010</year><volume>11</volume><fpage>174</fpage><pub-id pub-id-type="doi">10.1186/1465-9921-11-174</pub-id><?supplied-pmid 21143860?><pub-id pub-id-type="pmid">21143860</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guichard</surname><given-names>C</given-names></name><etal/></person-group><article-title>Axonemal dynein intermediate-chain gene (DNAI1) mutations result in situs inversus and primary ciliary dyskinesia (Kartagener syndrome)</article-title><source>Am. J. Hum. Genet.</source><year>2001</year><volume>68</volume><fpage>1030</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1086/319511</pub-id><?supplied-pmid 11231901?><pub-id pub-id-type="pmid">11231901</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakhleh</surname><given-names>N</given-names></name><etal/></person-group><article-title>High prevalence of respiratory ciliary dysfunction in congenital heart disease patients with heterotaxy</article-title><source>Circulation.</source><year>2012</year><volume>125</volume><fpage>2232</fpage><lpage>2242</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.079780</pub-id><?supplied-pmid 22499950?><pub-id pub-id-type="pmid">22499950</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zariwala</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Mutations of DNAI1 in primary ciliary dyskinesia: evidence of founder effect in a common mutation</article-title><source>Am. J. Respir. Crit. Care Med.</source><year>2006</year><volume>174</volume><fpage>858</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1164/rccm.200603-370OC</pub-id><?supplied-pmid 16858015?><pub-id pub-id-type="pmid">16858015</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noone</surname><given-names>PG</given-names></name><etal/></person-group><article-title>Primary ciliary dyskinesia: diagnostic and phenotypic features</article-title><source>Am. J. Respir. Crit. Care Med.</source><year>2004</year><volume>169</volume><fpage>459</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1164/rccm.200303-365OC</pub-id><?supplied-pmid 14656747?><pub-id pub-id-type="pmid">14656747</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knowles</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Mutations of DNAH11 in patients with primary ciliary dyskinesia with normal ciliary ultrastructure</article-title><source>Thorax.</source><year>2012</year><volume>67</volume><fpage>433</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1136/thoraxjnl-2011-200301</pub-id><?supplied-pmid 22184204?><pub-id pub-id-type="pmid">22184204</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morillas</surname><given-names>HN</given-names></name><name><surname>Zariwala</surname><given-names>M</given-names></name><name><surname>Knowles</surname><given-names>MR</given-names></name></person-group><article-title>Genetic causes of bronchiectasis: primary ciliary dyskinesia</article-title><source>Respiration.</source><year>2007</year><volume>74</volume><fpage>252</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1159/000101783</pub-id><?supplied-pmid 17534128?><pub-id pub-id-type="pmid">17534128</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Callaghan</surname><given-names>C</given-names></name><name><surname>Rutman</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>GM</given-names></name><name><surname>Hirst</surname><given-names>RA</given-names></name></person-group><article-title>Inner dynein arm defects causing primary ciliary dyskinesia: repeat testing required</article-title><source>Eur. Respir. J.</source><year>2011</year><volume>38</volume><fpage>603</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1183/09031936.00108410</pub-id><?supplied-pmid 21406509?><pub-id pub-id-type="pmid">21406509</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olin</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Diagnostic yield of nasal scrape biopsies in primary ciliary dyskinesia: a multicenter experience</article-title><source>Pediatr. Pulmonol.</source><year>2011</year><volume>46</volume><fpage>483</fpage><lpage>488</lpage><?supplied-pmid 21284095?><pub-id pub-id-type="pmid">21284095</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="other">Lucas, J. S. <italic>et al</italic>. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. <italic>Eur</italic>. <italic>Respir</italic>. <italic>J</italic>. <bold>49</bold> (2017).</mixed-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>R</given-names></name><etal/></person-group><article-title>An evaluation of copy number variation detection tools from whole-exome sequencing data</article-title><source>HUM MUTAT.</source><year>2014</year><volume>35</volume><fpage>899</fpage><pub-id pub-id-type="doi">10.1002/humu.22537</pub-id><?supplied-pmid 24599517?><pub-id pub-id-type="pmid">24599517</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rafiullah</surname><given-names>R</given-names></name><etal/></person-group><article-title>Homozygous missense mutation in the LMAN2L gene segregates with intellectual disability in a large consanguineous Pakistani family</article-title><source>J. Med. Genet.</source><year>2016</year><volume>53</volume><fpage>138</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1136/jmedgenet-2015-103179</pub-id><?supplied-pmid 26566883?><pub-id pub-id-type="pmid">26566883</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>RC</given-names></name><etal/></person-group><article-title>ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing</article-title><source>Genet. Med.</source><year>2013</year><volume>15</volume><fpage>565</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1038/gim.2013.73</pub-id><?supplied-pmid 23788249?><pub-id pub-id-type="pmid">23788249</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hjeij</surname><given-names>R</given-names></name><etal/></person-group><article-title>ARMC4 mutations cause primary ciliary dyskinesia with randomization of left/right body asymmetry</article-title><source>Am. J. Hum. Genet.</source><year>2013</year><volume>93</volume><fpage>357</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2013.06.009</pub-id><?supplied-pmid 23849778?><pub-id pub-id-type="pmid">23849778</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarkar</surname><given-names>A</given-names></name><etal/></person-group><article-title>DYX1C1 is required for axonemal dynein assembly and ciliary motility</article-title><source>Nat. Genet.</source><year>2013</year><volume>45</volume><fpage>995</fpage><lpage>1003</lpage><pub-id pub-id-type="doi">10.1038/ng.2707</pub-id><?supplied-pmid 23872636?><pub-id pub-id-type="pmid">23872636</pub-id></element-citation></ref></ref-list></back></article>